|
1) 下瀬川徹, 佐藤賢一, 正宗 淳, 他. 急性膵炎, 重症急性膵炎の全国調査. 厚生労働科学研究費補助金難治性疾患克服事業難治性膵疾患に関する調査研究平成21年度総合研究報告書. 2010; 35-8
|
|
|
|
|
2) 廣田昌彦. I. 急性膵炎 2. 成因と病態. 日本内科学会雑誌. 2010; 99: 9-14
|
|
|
|
|
|
3) Al Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol. 2008; 14: 675-84
|
|
|
|
|
4) Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006; 93: 518-30
|
|
|
|
|
|
5) Foitzik T, Eibl G, Hotz B, et al. Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications. Dig Dis Sci. 2002; 47: 130-8
|
|
|
|
|
|
6) Fujimura Y, Matsumoto M. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med. 2010; 49: 7-15
|
|
|
|
|
7) Morioka C, Uemura M, Matsuyama T, et al. ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis. Scand J Gastroenterol. 2008; 43: 1387-96
|
|
|
|
|
|
8) Uemura M, Fujimura Y, Ko S, et al. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010; 91: 20-9
|
|
|
|
|
|
9) 藤村吉博. 血栓性血小板減少性紫斑病の診断と治療. 日本医事新報. 2009; 4435: 45-51
|
|
|
|
|
|
10) Uemura M, Tatsumi K, Matsumoto M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005; 106: 922-4
|
|
|
|
|
|
11) Kokame K, Nobe Y, Kokubo Y, et al. FRETSVWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005; 129: 93-100
|
|
|
|
|
|
12) Kato S, Matsumoto M, Matsuyama T, et al. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion. 2006; 46: 1444-52
|
|
|
|
|
|
13) Ruiz J, Koduri PR, Valdivieso M, et al. Refractory post-pancreatitis thrombotic thrombocytopenic purpura: response to rituximab. Ann Hematol. 2005; 84: 267-8
|
|
|
|
|
|
14) Swisher KK, Doan JT, Vesely SK, et al. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published report. Haematologica. 2007; 92: 936-43
|
|
|
|
|
|
15) Bergmann IP, Kremer Hovinga JA, Lämmle B, et al. Acute pancreatitis and thrombotic thrombocytopenic purpura. Eur J Med Res. 2008; 13: 481-2
|
|
|
|
|
|
16) McDonald V, Laffan M, Benjamin S, et al. Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. Br J Haematol. 2009; 144: 430-3
|
|
|
|
|
|
17) Morioka C, Uemura M, Matsumoto M, et al. Persistent detection of unusually large von Willebrand factor multimer despite moderately decreased ADAMTS13 in severe acute pancreatitis (submitted)
|
|
|
|
|
|
18) Olsen H. Thrombotic thrombocytopenic purpura as a cause of pancreatitis. Report of a case and review of the literature. Am J Dig Dis. 1973; 18: 238-46
|
|
|
|
|
|
19) Tsuji Y, Yamamoto H, Yazumi S, et al. Perfusion computerized tomography can predict pancreatic necrosis in early stages of severe acute pancreatitis. Clin Gastroenterol Hepatol. 2007; 5: 1484-92
|
|
|
|
|
|
20) Kusterer K, Poschmann T, Friedemann A, et al. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol. 1993; 265: G165-71
|
|
|
|
|
|
21) Bernardo A, Ball C, Nolasco L, et al. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood. 2004; 104: 100-6
|
|
|
|
|
|
22) Claus RA, Bockmeyer CL, Sossdorf M, et al. The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure？ Curr Mol Med. 2010; 10: 236-48
|
|
|
|
|
|
23) Bockmeyer CL, Claus RA, Budde U, et al. Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica. 2008; 93: 137-40
|
|
|
|
|
|
24) Hiura H, Matsui T, Matsumoto M, et al. Proteolytic fragmentation and sugar chains of plasma ADAMTS13 purified by a conformation-dependent monoclonal antibody. J Biochem. 2010; 148: 403-11
|
|
|
|
|